#efavirenz

Harvoni and the combination of Sovaldi and daclatasvir were the least likely to cause a severe reaction with the HIV regimens of a cohort of H...

People who coinfected with HIV and hepatitis C looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug inte...

Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.

Twelve weeks of Gilead Sciences newly approved Harvoni cured nearly all people with genotype 1 of hepatitis C who were coinfected with HIV in...

Sovaldi (sofosbuvir) and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatiti...

The Sovaldi/ledipasvir combination pill to treat hepatitis C does not have a clinically significant impact on five common HIV antiretrovirals.

At the recent Conference on Retroviruses and Opportunistic Infections researchers reveled in promising new data on hepatitis C therapies.

Interim results from a trial of the hep C drug faldaprevir, given to people coinfected with hep C and HIV, have shown an 80 percent early succ...

Important preliminary recommendations involving the use of hepatitis C protease inhibitors among people living with HIV are provided by U.S. D...

The hepatitis C protease inhibitor Victrelis (boceprevir) has some significant drug-drug interactions with common Norvir (ritonavir)-boosted p...

The U.S. DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents has come nearly full circle...

Tobacco and alcohol interact negatively with efavirenz (found in Sustiva and Atripla) in people who are genetically predisposed to clear efa...

The HIV drug efavirenz (found in Sustiva and Atripla) does not substantially worsen psychiatric side effects of interferon, a treatment for...